Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

导出 OA

翻译打印收藏纠错

作者： Nobuhiko,Fukuda ^[1] ; Nobuyuki,Horita ^[1] ; Ayami,Kaneko ^[1] ; Atsushi,Goto ^[2] ; Takeshi,Kaneko ^[1] ; Erika,Ota ^[3] ; Kayleigh M,Kew ^[4]

作者单位： Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. ^[1] Metabolic Epidemiology Section, Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan. ^[2] Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan. ^[3] Cochrane Central Executive, London, UK. ^[4]

主题词男(雄)性(Male);人类(Humans);中年人(Middle Aged);女(雌)性(Female);毒蕈碱拮抗剂(Muscarinic Antagonists);肾上腺素能β-2受体激动剂(Adrenergic beta-2 Receptor Agonists);生活质量(Quality of Life);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);肾上腺皮质激素类(Adrenal Cortex Hormones);肺炎(Pneumonia)

DOI 10.1002/14651858.CD012066.pub3

PMID 37276335

发布时间 2024-06-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

The Cochrane database of systematic reviews

2023年6卷

CD012066页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews

相似文献

The Cochrane database of systematic reviews

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews

相似文献

The Cochrane database of systematic reviews

相关期刊

检索历史清除